25
Agencies for Detecting Proliferative Diabetic Retinopathy. Telemedicine
and e-health 2005 ; 11:641-651.
34.
Joshi GD ,Sivaswamy J . DrishtiCare: A Telescreening Platform for Dia-
betic Retinopathy Powered with Fundus Image Analysis. J Diabetes Sci
Technol 2011;5(1):23-35.
35.
Liesenfeld B, Kohner E, Piehlmeier W , Kluthe S , Aldington S , Porta M,
Bek T, Obermaier M , Mayer H, Mann G, Holle R , Hepp KD A teleme-
dical approach to the screening of diabetic retinopathy: digital fundus
photography. Diabetes 2Care 2 3 :3 4 5–348, 2000.
36.
Younis N, Broadbent DM , Harding SP , and Vora JP .Prevalence of dia-
betic eye disease in patients entering a systematic primary care-based eye
screening Programme. Diabet. Med. 2002 ; 19, :1014-1021.
37.
Brown MM, Brown GC, Sharma S, Landy J. Health care economic analy-
ses and value-based medicine. Surv Ophthalmol 2003; 48:204-223.
38.
Olafsdottir E, Andersson DK, Stefansson E. Visual acuity in a population
with regular screening for type 2 diabetes mellitus and eye disease. Acta
Ophthalmol Scand 2007;85:40–5.
39.
Klein R, Klein BE, Moss SE, et al. The Wisconsin Study of the Epidemiolo-
gy of Diabetic Retinopathy III. Prevalence and risk of diabetes when the
age of diagnosis is 30 years or more. Arch Ophthalmol 1984 ;102:527-
532.
40.
Klein R ,Klein B , Moss S , Davis M , and Demets D , “The Wisconsin
epidemiologic study of diabetic retinopathy II. Prevalence and risk of
diabetic retinopathy when age at diagnosis is less than 30 years,” Arch.
Ophthalmol.1984;102 :520–526.
41.
Sharma S, Oliver-Fernandez A, Bakal J, et al. Utilities associated with
diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol
2003; 87:259—261.
42.
Tung T-H, Shih HC, Chen S-J, Chou P, Liu J-H –Economoc evaluation
of screening diabetic retinopathy among Chinese typee 2 diabetics :A
community-baased study in Kinmen, Taiwan . J Epidemiol 2008;18:2254-
232.
43.
Foulds WS, MacCuish AC , Barrie T. Diabetic retinopathy in the west
Scotland: its detection, prevalence and cost- effectiveness of a proposed
screening program .Health Boll(Edinb) 1983;41:318-326.
44.
James M , Turner D, Broadbent DM, Vora J, Harding S. Cost-effective
analysis of screening for sight threatening diabetic eye disease. BMJ
2000;329: 1627-1631.
45.
Crijns Hospital; Casparie AF; Hendrikse F. Future need of eye care for
patients with diabetes mellitus, costs and effectiveness. Ned. Tijdschr.
Geneeska. 1995; 139(26): 1336-1341.
46.
Javitt JC. Cost savings associated with detection and treatment of diabetic
eye disease. Pharmaco Economics 1995;8(Suppl 1):33-9.
47.
Javitt JC, Aiello L. Cost-effectiveness of detecting and treating diabetic
retinopathy. Ann Intern Med. 1996;124:164-169.
48.
Javitt JC, Aiello L. Cost-effectiveness of detecting and treating diabetic